Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00019344 | Flavopiridol in Treating Patients With Refractory Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00020254 | Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer | completed | Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Apr 29, 2015 | clinicaltrials |
| NCT00500110 | Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer | completed | Phase 2 | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 28, 2015 | clinicaltrials |
| NCT00975429 | Study Using WST11 in Patients With Localized Prostate Cancer | completed | Phase 2 | 86 | Steba Biotech S.A.OTHER | 3 | Apr 28, 2015 | clinicaltrials |
| NCT01056562 | An Alternative to A Fixed Schedule In Management Of Prostate Cancer(TADS) | completed | — | 82 | University Health Network, TorontoOTHER | 1 | Apr 27, 2015 | clinicaltrials |
| NCT01062503 | Duration of Suppression of Bone Turnover Following Treatment With Zoledronic Acid in Men With Metastatic CRPC(SubDueP) | completed | — | 48 | University Health Network, TorontoOTHER | 1 | Apr 27, 2015 | clinicaltrials |
| NCT02425163 | Shear Wave Elastography of Prostate Cancer(ElaProC) | completed | Phase 2 | 73 | University of MagdeburgOTHER | 1 | Apr 23, 2015 | clinicaltrials |
| NCT00673127 | Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer(KHAD) | completed | Phase 2 | 57 | Beth Israel Deaconess Medical CenterOTHER | 2 | Apr 22, 2015 | clinicaltrials |
| NCT00041847 | Gene-Environment Interaction in Prostate Cancer | completed | — | 881 | National Institute of Environmental Health Sciences (NIEHS)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00450957 | Lycopene in Healthy Male Participants | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Apr 15, 2015 | clinicaltrials |
| NCT00219219 | Zoledronic Acid in the Prevention of Skeletal-related Events in Hormone Refractory and Hormone-sensitive Prostate Cancer Patients With Bone Metastases | completed | Phase 4 | — | NovartisINDUSTRY | 1 | Apr 14, 2015 | clinicaltrials |
| NCT00012935 | Treatment Decision Intervention for Veterans With Prostate Cancer | completed | N/A | 100 | US Department of Veterans AffairsFED | 1 | Apr 7, 2015 | clinicaltrials |
| NCT00013247 | Facilitating Shared Decisionmaking About Prostate Cancer Screening | completed | N/A | 1,152 | US Department of Veterans AffairsFED | 1 | Apr 7, 2015 | clinicaltrials |
| NCT01826617 | Configuration of a New Prostate Disease Nomogram Predicting Prostate Biopsy Outcome | completed | — | 400 | St. Luke's Medical Center, PhilippinesOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT01886547 | 2013 Annual National Digital Rectal Exam (DRE) Day Study | completed | — | 925 | St. Luke's Medical Center, PhilippinesOTHER | 1 | Apr 7, 2015 | clinicaltrials |
| NCT00215683 | An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer | completed | Phase 2 / Phase 3 | 137 | Ferring PharmaceuticalsINDUSTRY | 7 | Apr 1, 2015 | clinicaltrials |
| NCT00585637 | Vitamin D for Chemoprevention | completed | Phase 1 | 328 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 1, 2015 | clinicaltrials |
| NCT00010231 | Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | completed | Phase 1 | 22 | University of PittsburghOTHER | 1 | Mar 30, 2015 | clinicaltrials |
| NCT00260611 | Study of Oxaliplatin and Taxotere in Prostate Cancer | completed | Phase 2 | 34 | University of PittsburghOTHER | 1 | Mar 25, 2015 | clinicaltrials |
| NCT02220517 | Randomized Study Comparing MR-guided in Bore Versus MRI/US Fusion-guided Prostate Biopsy | completed | N/A | 480 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Mar 24, 2015 | clinicaltrials |
| NCT00753415 | A Study of V934/V935 Vaccine in Cancer Participants With Selected Solid Tumors (V934-002) | completed | Phase 1 | 37 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Mar 17, 2015 | clinicaltrials |
| NCT01533246 | Linsitinib in Treating Patients With Asymptomatic or Mildly Symptomatic Metastatic Prostate Cancer | completed | Phase 2 | 17 | National Cancer Institute (NCI)NIH | 1 | Mar 13, 2015 | clinicaltrials |
| NCT00080899 | Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer | completed | Phase 2 | 23 | National Cancer Institute (NCI)NIH | 1 | Mar 6, 2015 | clinicaltrials |
| NCT02382094 | Clinical Trial to Study Quality of Life in Prostate Cancer Patients by Randomizing Anti-androgen Versus Total Androgen Blockage Prior to Curative Intended Radiation Therapy | completed | Phase 3 | 110 | Karolinska University HospitalOTHER | 0 | Mar 6, 2015 | clinicaltrials |
| NCT01242631 | Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer(RADIT) | completed | Phase 2 | 25 | Hannover Medical SchoolOTHER | 1 | Feb 25, 2015 | clinicaltrials |
| NCT00441337 | A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies(MDX1106-01) | completed | Phase 1 | 39 | Bristol-Myers SquibbINDUSTRY | 1 | Feb 20, 2015 | clinicaltrials |
| NCT01790451 | Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans | completed | Phase 1 | 16 | Clinical Research Office of the Endourological SocietyOTHER | 1 | Feb 20, 2015 | clinicaltrials |
| NCT01300104 | Feasibility Study on a Nordic Lifestyle Intervention Trial Among Men With Prostate Cancer | completed | N/A | 24 | Danish Cancer SocietyOTHER | 1 | Feb 19, 2015 | clinicaltrials |
| NCT02055716 | Sulforadex in Healthy Human Males MAD | completed | Phase 1 | 18 | Evgen PharmaINDUSTRY | 1 | Feb 10, 2015 | clinicaltrials |
| NCT00631527 | Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer | completed | Phase 1 | 19 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 29, 2015 | clinicaltrials |
| NCT00151086 | Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer | completed | Phase 1 / Phase 2 | 33 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 22, 2015 | clinicaltrials |
| NCT00150995 | Tetrathiomolybdate in Hormone Refractory Prostate Cancer | completed | Phase 2 | 19 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 21, 2015 | clinicaltrials |
| NCT00151047 | Docetaxel Plus Capecitabine in Newly Diagnosed Localized or Locally Advanced Prostate Cancer | completed | Phase 2 | 15 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 21, 2015 | clinicaltrials |
| NCT00151060 | Estramustine, Etoposide and Paclitaxel Treatment for Hormonally Responsive Adenocarcinoma of the Prostate | completed | Phase 2 | 28 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jan 21, 2015 | clinicaltrials |
| NCT00846976 | Treatment Protocol to Monitor the Safety of a 200 mg Dose of Bicalutamide in Patients With Advanced Prostate Cancer | completed | Phase 3 | 101 | AstraZenecaINDUSTRY | 1 | Jan 21, 2015 | clinicaltrials |
| NCT00134355 | Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer | completed | Phase 2 | 5 | University of Michigan Rogel Cancer CenterOTHER | 0 | Jan 19, 2015 | clinicaltrials |
| NCT00913263 | An Efficacy and Safety Study With Licroca Depot, a Controlled Release Product, Injected Into the Prostate(2-HOF) | completed | Phase 1 / Phase 2 | 24 | Lidds ABINDUSTRY | 1 | Jan 19, 2015 | clinicaltrials |
| NCT01324583 | Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer | completed | Phase 1 | 48 | SanofiINDUSTRY | 1 | Jan 7, 2015 | clinicaltrials |
| NCT00949338 | Comparing Two Sets of Bladder-Filling Instructions in Treating Patients Undergoing Radiation Therapy For Prostate Cancer. ICORG 05-04 | completed | N/A | 183 | Cancer Trials IrelandNETWORK | 1 | Dec 31, 2014 | clinicaltrials |
| NCT00937833 | Return of Continence Following Robot-Assisted Radical Prostatectomy With or Without a Urethrovesical Sling | completed | N/A | 150 | Cook Group IncorporatedINDUSTRY | 1 | Dec 29, 2014 | clinicaltrials |
| NCT01244568 | Decision Support Interventions (DESI) for Prostate Cancer Screening and Treatment - Study 2 | completed | N/A | 218 | University of North Carolina, Chapel HillOTHER | 1 | Dec 23, 2014 | clinicaltrials |
| NCT00666666 | R-(-)-Gossypol and Androgen Ablation Therapy in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2014 | clinicaltrials |
| NCT02139371 | Evaluation of a New Radiotracer (64Cu-DOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography | completed | Early Phase 1 | 10 | Rigshospitalet, DenmarkOTHER | 1 | Dec 12, 2014 | clinicaltrials |
| NCT02064283 | Early Assessment of Treatment Response Using Functional Diffusion Mapping | completed | N/A | 20 | University of Michigan Rogel Cancer CenterOTHER | 1 | Dec 9, 2014 | clinicaltrials |
| NCT01497431 | Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants | completed | Phase 1 | 66 | National Cancer Institute (NCI)NIH | 1 | Nov 26, 2014 | clinicaltrials |
| NCT02292524 | Prostate Biomarkers in Men Consuming Tomato Products | completed | N/A | 33 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Nov 17, 2014 | clinicaltrials |
| NCT01601691 | Protection of Rectum From High Radiation Doses | completed | N/A | 10 | University of OuluOTHER | 1 | Nov 14, 2014 | clinicaltrials |
| NCT01610050 | A Phase I Study of LFA102 in Japanese Patients | completed | Phase 1 | 14 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 11, 2014 | clinicaltrials |
| NCT00751205 | Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC) | completed | Phase 2 | 150 | BayerINDUSTRY | 6 | Oct 28, 2014 | clinicaltrials |
| NCT01729442 | Assessment of HIFU-induced Prostate Necrosis With Shear-wave Ultrasound Elastography(IDITOP-1) | completed | N/A | 30 | Hospices Civils de LyonOTHER | 1 | Oct 22, 2014 | clinicaltrials |
Data updated 24 days agoSource updated Apr 29, 2015source: clinicaltrials